175 related articles for article (PubMed ID: 20218969)
1. Apolipoprotein E inhibits toll-like receptor (TLR)-3- and TLR-4-mediated macrophage activation through distinct mechanisms.
Zhu Y; Kodvawala A; Hui DY
Biochem J; 2010 Apr; 428(1):47-54. PubMed ID: 20218969
[TBL] [Abstract][Full Text] [Related]
2. Ketamine inhibits tumor necrosis factor-alpha and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation.
Wu GJ; Chen TL; Ueng YF; Chen RM
Toxicol Appl Pharmacol; 2008 Apr; 228(1):105-13. PubMed ID: 18191973
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E suppresses the type I inflammatory response in vivo.
Ali K; Middleton M; Puré E; Rader DJ
Circ Res; 2005 Oct; 97(9):922-7. PubMed ID: 16179587
[TBL] [Abstract][Full Text] [Related]
4. Tunicamycin inhibits Toll-like receptor-activated inflammation in RAW264.7 cells by suppression of NF-κB and c-Jun activity via a mechanism that is independent of ER-stress and N-glycosylation.
Kim SY; Hwang JS; Han IO
Eur J Pharmacol; 2013 Dec; 721(1-3):294-300. PubMed ID: 24056124
[TBL] [Abstract][Full Text] [Related]
5. Aging negatively skews macrophage TLR2- and TLR4-mediated pro-inflammatory responses without affecting the IL-2-stimulated pathway.
Boehmer ED; Meehan MJ; Cutro BT; Kovacs EJ
Mech Ageing Dev; 2005 Dec; 126(12):1305-13. PubMed ID: 16154177
[TBL] [Abstract][Full Text] [Related]
6. Expression and function of Toll-like receptors in chicken heterophils.
Kogut MH; Iqbal M; He H; Philbin V; Kaiser P; Smith A
Dev Comp Immunol; 2005; 29(9):791-807. PubMed ID: 15936435
[TBL] [Abstract][Full Text] [Related]
7. Different Toll-like receptor agonists induce distinct macrophage responses.
Jones BW; Means TK; Heldwein KA; Keen MA; Hill PJ; Belisle JT; Fenton MJ
J Leukoc Biol; 2001 Jun; 69(6):1036-44. PubMed ID: 11404392
[TBL] [Abstract][Full Text] [Related]
8. Procyanidin dimer B2-mediated IRAK-M induction negatively regulates TLR4 signaling in macrophages.
Sung NY; Yang MS; Song DS; Kim JK; Park JH; Song BS; Park SH; Lee JW; Park HJ; Kim JH; Byun EB; Byun EH
Biochem Biophys Res Commun; 2013 Aug; 438(1):122-8. PubMed ID: 23872113
[TBL] [Abstract][Full Text] [Related]
9. DLK1 is a novel inflammatory inhibitor which interferes with NOTCH1 signaling in TLR-activated murine macrophages.
González MJ; Ruiz-García A; Monsalve EM; Sánchez-Prieto R; Laborda J; Díaz-Guerra MJ; Ruiz-Hidalgo MJ
Eur J Immunol; 2015 Sep; 45(9):2615-27. PubMed ID: 26115479
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effects of benzenediamine derivate FC-98 on sepsis injury in mice via suppression of JNK, NF-κB and IRF3 signaling pathways.
Song Y; Liu X; Yue H; Ji J; Dou H; Hou Y
Mol Immunol; 2015 Oct; 67(2 Pt B):183-92. PubMed ID: 26032013
[TBL] [Abstract][Full Text] [Related]
11. Zedoarondiol isolated from the rhizoma of Curcuma heyneana is involved in the inhibition of iNOS, COX-2 and pro-inflammatory cytokines via the downregulation of NF-kappaB pathway in LPS-stimulated murine macrophages.
Cho W; Nam JW; Kang HJ; Windono T; Seo EK; Lee KT
Int Immunopharmacol; 2009 Aug; 9(9):1049-57. PubMed ID: 19398040
[TBL] [Abstract][Full Text] [Related]
12. Melanoma inhibits macrophage activation by suppressing toll-like receptor 4 signaling.
Clarke JH; Cha JY; Walsh MD; Gamboni-Robertson F; Banerjee A; Reznikov LL; Dinarello CA; Harken AH; McCarter MD
J Am Coll Surg; 2005 Sep; 201(3):418-25. PubMed ID: 16125076
[TBL] [Abstract][Full Text] [Related]
13. A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling.
Ii M; Matsunaga N; Hazeki K; Nakamura K; Takashima K; Seya T; Hazeki O; Kitazaki T; Iizawa Y
Mol Pharmacol; 2006 Apr; 69(4):1288-95. PubMed ID: 16373689
[TBL] [Abstract][Full Text] [Related]
14. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH
Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482
[TBL] [Abstract][Full Text] [Related]
15. The role of MAPK in Kupffer cell toll-like receptor (TLR) 2-, TLR4-, and TLR9-mediated signaling following trauma-hemorrhage.
Thobe BM; Frink M; Hildebrand F; Schwacha MG; Hubbard WJ; Choudhry MA; Chaudry IH
J Cell Physiol; 2007 Mar; 210(3):667-75. PubMed ID: 17117477
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide prevents valproic acid-induced apoptosis via activation of nuclear factor-κB and inhibition of p53 activation.
Tsolmongyn B; Koide N; Odkhuu E; Haque A; Naiki Y; Komatsu T; Yoshida T; Yokochi T
Cell Immunol; 2013 Apr; 282(2):100-5. PubMed ID: 23770718
[TBL] [Abstract][Full Text] [Related]
17. Signal-transducing mechanisms of ketamine-caused inhibition of interleukin-1 beta gene expression in lipopolysaccharide-stimulated murine macrophage-like Raw 264.7 cells.
Chen TL; Chang CC; Lin YL; Ueng YF; Chen RM
Toxicol Appl Pharmacol; 2009 Oct; 240(1):15-25. PubMed ID: 19540866
[TBL] [Abstract][Full Text] [Related]
18. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3.
Kulka M; Alexopoulou L; Flavell RA; Metcalfe DD
J Allergy Clin Immunol; 2004 Jul; 114(1):174-82. PubMed ID: 15241362
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of toll-like receptor 4 and antagonized by bone morphogenetic protein 7.
Bobacz K; Sunk IG; Hofstaetter JG; Amoyo L; Toma CD; Akira S; Weichhart T; Saemann M; Smolen JS
Arthritis Rheum; 2007 Jun; 56(6):1880-93. PubMed ID: 17530716
[TBL] [Abstract][Full Text] [Related]
20. Responsiveness of intestinal epithelial cell lines to lipopolysaccharide is correlated with Toll-like receptor 4 but not Toll-like receptor 2 or CD14 expression.
Böcker U; Yezerskyy O; Feick P; Manigold T; Panja A; Kalina U; Herweck F; Rossol S; Singer MV
Int J Colorectal Dis; 2003 Jan; 18(1):25-32. PubMed ID: 12458377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
